Literature DB >> 27251602

5-Fluorouracil-induced acute reversible heart failure not explained by coronary spasms, myocarditis or takotsubo: lessons from MRI.

Yama Fakhri1, Morten Dalsgaard2, Dorte Nielsen3, Per Lav Madsen2.   

Abstract

A 69-year-old woman presented with arterial hypotension, pulmonary oedema and a severely depressed left ventricular ejection fraction (LVEF) of 25% only 3 days after having received her first treatment for colorectal cancer with 5-fluorouracil (5-FU)-based therapy. The ECG demonstrated widespread ST-segment depression and echocardiography showed uniform hypokinesia of all left ventricular (LV) myocardial segments without signs of regional LV ballooning. Coronary angiography was normal and the patient gained full recovery after receiving treatment with heart failure medication. Interestingly, cardiac MRI scan 9 days later showed a normal LVEF with signs of neither myocardial oedema nor necrosis. Despite the high therapeutic efficacy of 5-FU in treatment of colorectal cancer, it is associated with undesired cardiac toxicities including coronary spasms, toxic inflammation and takotsubo cardiomyopathy. However, our patient did not fulfil the diagnostic criteria for the aforementioned complications. Based on this case report, we discuss alternative mechanisms including myocardial adenosine triphosphate depletion suggested from animal experiments. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27251602      PMCID: PMC4904399          DOI: 10.1136/bcr-2015-213783

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  30 in total

Review 1.  Takotsubo cardiomyopathy and Fluorouracil: case report and review of the literature.

Authors:  Michael R Grunwald; Lynn Howie; Luis Alberto Diaz
Journal:  J Clin Oncol       Date:  2011-12-05       Impact factor: 44.544

Review 2.  The failing heart--an engine out of fuel.

Authors:  Stefan Neubauer
Journal:  N Engl J Med       Date:  2007-03-15       Impact factor: 91.245

3.  The effects of 5-fluorouracil on contractility and oxygen uptake of the isolated perfused rat heart.

Authors:  H Millart; L Brabant; M Lorenzato; D Lamiable; O Albert; H Choisy
Journal:  Anticancer Res       Date:  1992 Mar-Apr       Impact factor: 2.480

4.  Is 5-fluorouracil-induced vasospasm a Kounis syndrome? A diagnostic challenge.

Authors:  C Y Karabay; C Gecmen; S M Aung; A Guler; O Candan; U Batgerel; A Kalayci; C Kirma
Journal:  Perfusion       Date:  2011-05-31       Impact factor: 1.972

Review 5.  Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction.

Authors:  Abhiram Prasad; Amir Lerman; Charanjit S Rihal
Journal:  Am Heart J       Date:  2008-01-31       Impact factor: 4.749

6.  A model system for measuring comparative toxicities of cardiotoxic drugs for cultured rat heart myocytes, endothelial cells and fibroblasts. II. Doxorubicin, 5-fluorouracil and cyclophosphamide.

Authors:  D G Wenzel; G N Cosma
Journal:  Toxicology       Date:  1984-11       Impact factor: 4.221

7.  5-Fluorouracil cardiotoxicity: left ventricular dysfunction and effect of coronary vasodilators.

Authors:  B Patel; R A Kloner; J Ensley; M Al-Sarraf; J Kish; J Wynne
Journal:  Am J Med Sci       Date:  1987-10       Impact factor: 2.378

8.  The appearance of endothelium in small arteries after treatment with 5-fluorouracil. An electron microscopic study of late effects in rabbits.

Authors:  M Cwikiel; J Eskilsson; J B Wieslander; U Stjernquist; M Albertsson
Journal:  Scanning Microsc       Date:  1996

9.  The clinical impact of late gadolinium enhancement in Takotsubo cardiomyopathy: serial analysis of cardiovascular magnetic resonance images.

Authors:  Yoshihisa Naruse; Akira Sato; Kazuyuki Kasahara; Kiwa Makino; Makoto Sano; Yasuyo Takeuchi; Shiro Nagasaka; Yasushi Wakabayashi; Hideki Katoh; Hiroshi Satoh; Hideharu Hayashi; Kazutaka Aonuma
Journal:  J Cardiovasc Magn Reson       Date:  2011-10-29       Impact factor: 5.364

10.  Acute cardiogenic shock induced by infusional 5-Fluorouracil.

Authors:  Jeffrey Sulpher; Franco Dattilo; Susan Dent; Michele Turek; M Neil Reaume; Christopher Johnson
Journal:  Case Rep Oncol Med       Date:  2014-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.